These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14158360)

  • 41. [Phospholine iodide and epitrate in glaucoma].
    Asayama R; Sakaue E; Ueno I; Maruyama K; Kondo T
    Nihon Ganka Kiyo; 1966 Feb; 17(2):229-40. PubMed ID: 6006621
    [No Abstract]   [Full Text] [Related]  

  • 42. Antidotes and potentiating agents for phospholine iodide.
    LEHMAN RA; FITCH HM; BLOCHI LP; JEWELL HA; NICHOLLS ME
    J Pharmacol Exp Ther; 1960 Mar; 128():307-17. PubMed ID: 14415357
    [No Abstract]   [Full Text] [Related]  

  • 43. [New drugs in glaucoma therapy].
    Riegel D; Duzanéc Z; Knapp E
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1968; 68():358-9. PubMed ID: 5756797
    [No Abstract]   [Full Text] [Related]  

  • 44. Electroconvulsive therapy and the chronic use of pseudocholinesterase-inhibitor (echothiophate iodide) eye drops for glaucoma. A case report.
    Messer GJ; Stoudemire A; Knos G; Johnson GC
    Gen Hosp Psychiatry; 1992 Jan; 14(1):56-60. PubMed ID: 1730402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [RESPIRATORY AND CIRCULATORY EXAMINATIONS USING A CHOLINESTERASE INHIBITOR].
    KIESEWETTER E
    Wien Klin Wochenschr; 1965 Mar; 77():158-60. PubMed ID: 14309378
    [No Abstract]   [Full Text] [Related]  

  • 46. Anticholinesterase eye drops--need for caution.
    Kinyon GE
    N Engl J Med; 1969 Jan; 280(1):53. PubMed ID: 5761726
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of echothiophate (phospholine iodide) in the treatment of glaucoma.
    LAWLOR RC; LEE PF
    Am J Ophthalmol; 1960 Apr; 49():808-13. PubMed ID: 14414703
    [No Abstract]   [Full Text] [Related]  

  • 48. Provocation of bronchospasm by eye drops.
    Fratto C
    Ann Intern Med; 1978 Mar; 88(3):362. PubMed ID: 629501
    [No Abstract]   [Full Text] [Related]  

  • 49. [Complications of medical therapy in glaucoma].
    Naveh-Floman N; Blumenthal M; Belkin M
    Harefuah; 1985 Mar; 108(6):274-7. PubMed ID: 3843393
    [No Abstract]   [Full Text] [Related]  

  • 50. Lcal administration of 1 per cent Ubretid in the handling of glaucoma, myasthenia gravis and esotropia.
    Ishikawa S; Tsukahara S; Sato Y
    Ophthalmologica; 1969; 159(4):339-62. PubMed ID: 5393688
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of 0.03% phospholine eyewash after eight years of use].
    Corbel M; Leser C
    Bull Soc Ophtalmol Fr; 1979; 79(8-9):741-3. PubMed ID: 555365
    [No Abstract]   [Full Text] [Related]  

  • 52. The clinical evaluation of echothiophate (phospholine iodide) in the treatment of glaucoma.
    GRAY LF; ROBINSON JP
    Am J Ophthalmol; 1960 May; 49():1162-5. PubMed ID: 13829115
    [No Abstract]   [Full Text] [Related]  

  • 53. Ocular tissue cholinesterases kinetics of enzyme activity and inhibition.
    Ellis PP
    Trans Am Ophthalmol Soc; 1971; 69():358-82. PubMed ID: 5005214
    [No Abstract]   [Full Text] [Related]  

  • 54. Echothiophate iodide therapy in children. Effect upon blood cholinesterase levels.
    Ellis PP; Esterdahl M
    Arch Ophthalmol; 1967 May; 77(5):598-601. PubMed ID: 6022729
    [No Abstract]   [Full Text] [Related]  

  • 55. Systemic effects of eye drops.
    Adler AG; McElwain GE; Merli GJ; Martin JH
    Arch Intern Med; 1982 Dec; 142(13):2293-4. PubMed ID: 7149872
    [No Abstract]   [Full Text] [Related]  

  • 56. [Activities of true and pseudo cholinesterases in the patients with a partial accommodative esotropia under phospholine iodide and Ubretid treatment (author's transl)].
    Kusayama M; Terakado R; Mukuno K; Ishikawa S
    Nippon Ganka Gakkai Zasshi; 1974 Feb; 78(2):93-9. PubMed ID: 4858850
    [No Abstract]   [Full Text] [Related]  

  • 57. Echothiophate (phospholine) iodide (217-MI) in treatment of glaucoma; further observations.
    KRISHNA N; LEOPOLD IH
    AMA Arch Ophthalmol; 1959 Aug; 62(2):300-13. PubMed ID: 13669812
    [No Abstract]   [Full Text] [Related]  

  • 58. The management of glaucoma in the indigent clinic patient with echothiophate iodide.
    COYLE JT; WEINER A; FRANK P; LEONARD A
    Am J Ophthalmol; 1961 Dec; 52():867-71. PubMed ID: 13881920
    [No Abstract]   [Full Text] [Related]  

  • 59. MERCURIAL PRESERVATIVES IN EYE-DROPS, OBSERVATIONS ON PATIENTS USING MIOTICS CONTAINING THIOMERSAL.
    ABRAMS JD; DAVIES TG; KLEIN M
    Br J Ophthalmol; 1965 Mar; 49(3):146-7. PubMed ID: 14271814
    [No Abstract]   [Full Text] [Related]  

  • 60. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.
    Holland MG
    Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.